- Filed
- Mar 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Mar 1, 2024 | 6.29M sh |
| Shares Diluted | Q2 2024 · Jan 31, 2024 | 26.08M sh |
| Shares Diluted | Q2 2024 · Jan 31, 2024 | 26.08M sh |
| Shares Diluted restated | Q2 2024 · Jan 31, 2023 | 6.45M sh |
| Shares Diluted restated | Q2 2024 · Jan 31, 2023 | 6.5M sh |
| Capex | Q2 2024 · Jan 31, 2024 | $1.7M |
| Capex | Q2 2024 · Jan 31, 2023 | $866K |
| Operating Cash Flow | Q2 2024 · Jan 31, 2024 | $6.66M |
| Operating Cash Flow | Q2 2024 · Jan 31, 2023 | $9.59M |
| Cash And Equivalents | Q2 2024 · Jan 31, 2024 | $276.42M |
| Cash And Equivalents | Q2 2024 · Jul 31, 2023 | $121.37M |
| Cash And Equivalents | Q2 2024 · Jan 31, 2023 | $62.43M |
| Stockholders Equity | Q2 2024 · Jan 31, 2024 | $77.36M |
| Stockholders Equity | Q2 2024 · Oct 31, 2023 | $71.67M |
| Stockholders Equity | Q2 2024 · Jul 31, 2023 | $68.62M |
| Stockholders Equity | Q2 2024 · Jan 31, 2023 | −$4.75M |
| Stockholders Equity | Q2 2024 · Oct 31, 2022 | −$8.52M |
| Stockholders Equity | Q2 2024 · Jul 31, 2022 | −$9.21M |
| Current Liabilities | Q2 2024 · Jan 31, 2024 | $75.62M |
| Current Liabilities | Q2 2024 · Jul 31, 2023 | $67.75M |
| Total Liabilities | Q2 2024 · Jan 31, 2024 | $97.62M |
| Total Liabilities | Q2 2024 · Jul 31, 2023 | $104.82M |
| Current Assets | Q2 2024 · Jan 31, 2024 | $321.37M |
| Current Assets | Q2 2024 · Jul 31, 2023 | $319.27M |
| Total Assets | Q2 2024 · Jan 31, 2024 | $412.72M |
| Total Assets | Q2 2024 · Jul 31, 2023 | $411.18M |
| Eps Diluted | Q2 2024 · Jan 31, 2024 | $0.18 |
| Eps Diluted | Q2 2024 · Jan 31, 2024 | $0.33 |
| Eps Diluted restated | Q2 2024 · Jan 31, 2023 | −$0.16 |
| Eps Diluted restated | Q2 2024 · Jan 31, 2023 | $0.52 |
| Eps Basic | Q2 2024 · Jan 31, 2024 | $0.18 |
| Eps Basic | Q2 2024 · Jan 31, 2024 | $0.33 |
| Eps Basic restated | Q2 2024 · Jan 31, 2023 | −$0.16 |
| Eps Basic restated | Q2 2024 · Jan 31, 2023 | $0.52 |
| Sga Expense | Q2 2024 · Jan 31, 2024 | $8.73M |
| Sga Expense | Q2 2024 · Jan 31, 2024 | $17.53M |
| Sga Expense | Q2 2024 · Jan 31, 2023 | $10.46M |
| Sga Expense | Q2 2024 · Jan 31, 2023 | $20.85M |
| Net Income | Q2 2024 · Jan 31, 2024 | $5.35M |
| Net Income | Q2 2024 · Jan 31, 2024 | $9.78M |
| Net Income | Q2 2024 · Jan 31, 2023 | −$526K |
| Net Income | Q2 2024 · Jan 31, 2023 | $4.43M |
| Operating Income | Q2 2024 · Jan 31, 2024 | $1.72M |
| Operating Income | Q2 2024 · Jan 31, 2024 | $3.53M |
| Operating Income | Q2 2024 · Jan 31, 2023 | $2.6M |
| Operating Income | Q2 2024 · Jan 31, 2023 | $6.48M |
| Gross Profit | Q2 2024 · Jan 31, 2024 | $11.35M |
| Gross Profit | Q2 2024 · Jan 31, 2024 | $22.82M |
| Gross Profit | Q2 2024 · Jan 31, 2023 | $13.06M |
| Gross Profit | Q2 2024 · Jan 31, 2023 | $27.33M |
| Cost Of Revenue | Q2 2024 · Jan 31, 2024 | $31.7M |
| Cost Of Revenue | Q2 2024 · Jan 31, 2024 | $61.56M |
| Cost Of Revenue | Q2 2024 · Jan 31, 2023 | $37.72M |
| Cost Of Revenue | Q2 2024 · Jan 31, 2023 | $74.81M |
| Revenue | Q2 2024 · Jan 31, 2024 | $43.05M |
| Revenue | Q2 2024 · Jan 31, 2024 | $84.39M |
| Revenue | Q2 2024 · Jan 31, 2023 | $50.78M |
| Revenue | Q2 2024 · Jan 31, 2023 | $102.14M |